Home

Alembic Pharmaceuticals PE Ratio

Image

Alembic Pharmaceuticals Ltd

NSE: APLLTD

PE

32.3

Last updated on: Aug 25, 2025

Key Highlights

  • The P/E Ratio of Alembic Pharmaceuticals Ltd is 32.3 as of 25 Aug 15:30 PM .
  • The P/E Ratio of Alembic Pharmaceuticals Ltd changed from 12.1 on March 2020 to 31.3 on March 2025 . This represents a CAGR of 17.16% over 6 years.
  • The Latest Trading Price of Alembic Pharmaceuticals Ltd is ₹ 979.15 as of 25 Aug 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 21.1 to 39.8 in 5 years. This represents a CAGR of 13.53%.
  • The PE Ratio of Automobile industry is 21.5. The PE Ratio of Finance industry is 19.4. The PE Ratio of IT - Software industry is 26.8. The PE Ratio of Pharmaceuticals industry is 32.2. The PE Ratio of Retail industry is 109.0. The PE Ratio of Textiles industry is 53.8 in 2025.

Historical P/E Ratio of Alembic Pharmaceuticals Ltd

No data available

Company Fundamentals for Alembic Pharmaceuticals Ltd

Image

Alembic Pharmaceuticals Ltd

NSE: APLLTD

Share Price

₹ 979.15

5.35 (0.55%)

stock direction

Last updated on: Aug 25, 2025

Market Price of Alembic Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Alembic Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
25 Aug 2025979.15
22 Aug 2025973.8
21 Aug 2025968.45
20 Aug 2025982.05
19 Aug 2025991.45
18 Aug 2025973.3
14 Aug 2025958.25
13 Aug 2025943.6
12 Aug 2025946.7
11 Aug 2025949.6

SWOT Analysis Of Alembic Pharmaceuticals Ltd

Strength

1

che

Weakness

2

che

Opportunity

0

che

Threats

1

che

BlinkX Score for Alembic Pharmaceuticals Ltd

Asset Value vs Market Value of Alembic Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/E Ratio

Company
leftMarket Capright
Alembic Pharmaceuticals Ltd19141
Sun Pharmaceutical Industries Ltd394187
Divis Laboratories Ltd163282
Cipla Ltd128619
Torrent Pharmaceuticals Ltd124706
Mankind Pharma Ltd107559

PE Ratio of Alembic Pharmaceuticals Ltd Explained

19141

Market cap

603

Earnings

32.3X

PE Ratio

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Alembic Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Alembic Pharmaceuticals Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Alembic Pharmaceuticals Ltd

No data available

* All values are in %

About Alembic Pharmaceuticals Ltd

  • Alembic Pharmaceuticals Limited manufactures and markets generic pharmaceutical products all over the world.
  • The company's state of the art research and manufacturing facilities are approved by regulatory authorities of many developed countries including the US FDA. The company is one of the leaders in branded generics in India. Alembic Pharmaceuticals Limited was incorporated on June 16, 2010 as a wholly owned subsidiary of Alembic Limited.
  • The company is engaged in pharmaceuticals business.
  • As per the Scheme of Arrangement, the 'Pharmaceutical Undertaking' of Alembic Limited got demerged and transferred to the Company with effect from April 1, 2010. In April 2011, the company ceased to be a subsidiary of Alembic Ltd consequent to the allotment of 13,35,15,914 equity shares of Rs 2 each to the shareholders of Alembic Ltd as per the scheme of arrangement.

Alembic Pharmaceuticals Ltd News Hub

Alembic Pharma receives USFDA approval for Dabigatran Etexilate Capsules

Alembic Pharmaceuticals has received final approval from the US Food & Drug Administration (USFDA) f

Read more

13 Aug 24

Alembic Pharma gets US FDA nod for anticoagulant Dabigatran

The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Pradaxa

Read more

13 Aug 24

Alembic Pharmaceuticals Ltd leads losers in 'A' group

Steel Authority of India Ltd, IFCI Ltd, Coffee Day Enterprises Ltd and Orient Cement Ltd are among t

Read more

09 Aug 24

Alembic Pharma Q1 PAT rises 12% YoY to Rs 135 cr

Revenue from operations grew 5.09% year on year (YoY) to Rs 1,561.73 crore in the quarter ended 30 J

Read more

08 Aug 24

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Alembic Pharmaceuticals Ltd

What is the current PE Ratio of Alembic Pharmaceuticals Ltd?

The Current PE Ratio of Alembic Pharmaceuticals Ltd is 32.28 as on 25 Aug 2025.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 32.2 as on 25 Aug 2025.

What was the PE Ratio of Alembic Pharmaceuticals Ltd last year?

The PE Ratio of Alembic Pharmaceuticals Ltd was 31.35 last year, now the PE ratio is 32.28, showing a year-on-year growth of 3.0%.

What does the PE Ratio of Alembic Pharmaceuticals Ltd indicate about its stock?

The PE Ratio of Alembic Pharmaceuticals Ltd is 32.28. This ratio indicates that investors are willing to pay 32.28 times the earnings per share for each share of Alembic Pharmaceuticals Ltd.

What is the PE Ratio Growth of Alembic Pharmaceuticals Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Alembic Pharmaceuticals Ltd grew by 3.0% whereas, the EPS ratio grew by -1.6.

How does the PE ratio of Alembic Pharmaceuticals Ltd compare to industry peers?

The PE ratio of Alembic Pharmaceuticals Ltd PE Ratio can indicate whether it is overvalued or undervalued compared to competitors in the same industry. A lower PE ratio may suggest an undervalued stock, while a higher PE ratio could indicate premium pricing.

Is a high PE ratio for Alembic Pharmaceuticals Ltd PE Ratio good or bad?

A high PE ratio may indicate strong future growth expectations, but it can also suggest overvaluation. It is best to compare it with industry averages and historical trends of Alembic Pharmaceuticals Ltd PE Ratio.

What factors influence the PE ratio of Alembic Pharmaceuticals Ltd PE Ratio?

The PE ratio of Alembic Pharmaceuticals Ltd PE Ratio is influenced by factors such as earnings growth, investor sentiment, macroeconomic conditions, and sector trends.

How often does the PE ratio of Alembic Pharmaceuticals Ltd PE Ratio change?

The PE ratio changes as the share price or earnings of Alembic Pharmaceuticals Ltd PE Ratio fluctuate, and it is updated whenever there is a significant movement in either of these factors.

Where can I find the latest PE ratio of Alembic Pharmaceuticals Ltd PE Ratio?

You can check the latest PE ratio of Alembic Pharmaceuticals Ltd PE Ratio on BlinkX Website above or any other stock market platforms, or at the company’s official website.

What is a good PE ratio for Alembic Pharmaceuticals Ltd PE Ratio?

A "good" PE ratio depends on industry standards and market conditions. It is advisable to compare Alembic Pharmaceuticals Ltd PE ratio with its historical average and competitors.

Can the PE ratio of Alembic Pharmaceuticals Ltd PE Ratio predict future stock performance?

While the Alembic Pharmaceuticals Ltd PE ratio is a useful indicator of valuation, it should be used alongside other financial metrics and market analysis to make informed investment decisions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions